192 related articles for article (PubMed ID: 20022731)
1. GABA concentration in schizophrenia patients and the effects of antipsychotic medication: a proton magnetic resonance spectroscopy study.
Tayoshi S; Nakataki M; Sumitani S; Taniguchi K; Shibuya-Tayoshi S; Numata S; Iga J; Ueno S; Harada M; Ohmori T
Schizophr Res; 2010 Mar; 117(1):83-91. PubMed ID: 20022731
[TBL] [Abstract][Full Text] [Related]
2. Metabolite changes and gender differences in schizophrenia using 3-Tesla proton magnetic resonance spectroscopy (1H-MRS).
Tayoshi S; Sumitani S; Taniguchi K; Shibuya-Tayoshi S; Numata S; Iga J; Nakataki M; Ueno S; Harada M; Ohmori T
Schizophr Res; 2009 Mar; 108(1-3):69-77. PubMed ID: 19097753
[TBL] [Abstract][Full Text] [Related]
3. Decreased GABA levels in anterior cingulate and basal ganglia in medicated subjects with panic disorder: a proton magnetic resonance spectroscopy (1H-MRS) study.
Ham BJ; Sung Y; Kim N; Kim SJ; Kim JE; Kim DJ; Lee JY; Kim JH; Yoon SJ; Lyoo IK
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):403-11. PubMed ID: 17141385
[TBL] [Abstract][Full Text] [Related]
4. Perceptual and cognitive effects of antipsychotics in first-episode schizophrenia: the potential impact of GABA concentration in the visual cortex.
Kelemen O; Kiss I; Benedek G; Kéri S
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():13-9. PubMed ID: 23954737
[TBL] [Abstract][Full Text] [Related]
5. [First and second generation antipsychotics and morphological and neurochemical brain changes in schizophrenia. Review of magnetic resonance imaging and proton spectroscopy findings].
Szulc A
Psychiatr Pol; 2007; 41(3):329-38. PubMed ID: 17900049
[TBL] [Abstract][Full Text] [Related]
6. Perisylvian GABA levels in schizophrenia and bipolar disorder.
Atagün Mİ; Şıkoğlu EM; Soykan Ç; Serdar Süleyman C; Ulusoy-Kaymak S; Çayköylü A; Algın O; Phillips ML; Öngür D; Moore CM
Neurosci Lett; 2017 Jan; 637():70-74. PubMed ID: 27890741
[TBL] [Abstract][Full Text] [Related]
7. Brain metabolite alterations in young adults at familial high risk for schizophrenia using proton magnetic resonance spectroscopy.
Tandon N; Bolo NR; Sanghavi K; Mathew IT; Francis AN; Stanley JA; Keshavan MS
Schizophr Res; 2013 Aug; 148(1-3):59-66. PubMed ID: 23791389
[TBL] [Abstract][Full Text] [Related]
8. Prefrontal GABA Levels Measured With Magnetic Resonance Spectroscopy in Patients With Psychosis and Unaffected Siblings.
Marenco S; Meyer C; Kuo S; van der Veen JW; Shen J; DeJong K; Barnett AS; Apud JA; Dickinson D; Weinberger DR; Berman KF
Am J Psychiatry; 2016 May; 173(5):527-34. PubMed ID: 26806873
[TBL] [Abstract][Full Text] [Related]
9. N-acetylaspartate (NAA) levels in selected areas of the brain in patients with chronic schizophrenia treated with typical and atypical neuroleptics: a proton magnetic resonance spectroscopy (1H MRS) study.
Szulc A; Galińska B; Tarasów E; Kubas B; Dzienis W; Konarzewska B; Poplawska R; Tomczak AA; Czernikiewicz A; Walecki J
Med Sci Monit; 2007 May; 13 Suppl 1():17-22. PubMed ID: 17507880
[TBL] [Abstract][Full Text] [Related]
10. Proton magnetic resonance spectroscopy study of brain metabolite changes after antipsychotic treatment.
Szulc A; Galinska B; Tarasow E; Waszkiewicz N; Konarzewska B; Poplawska R; Bibulowicz D; Simonienko K; Walecki J
Pharmacopsychiatry; 2011 Jun; 44(4):148-57. PubMed ID: 21710405
[TBL] [Abstract][Full Text] [Related]
11. Effect of Electroconvulsive Therapy on Medial Prefrontal γ-Aminobutyric Acid Among Schizophrenia Patients: A Proton Magnetic Resonance Spectroscopy Study.
Xia M; Wang J; Sheng J; Tang Y; Li C; Lim K; He B; Li C; Xu Y; Wang J
J ECT; 2018 Dec; 34(4):227-232. PubMed ID: 29877964
[TBL] [Abstract][Full Text] [Related]
12. Proton magnetic resonance spectroscopy during initial treatment with antipsychotic medication in schizophrenia.
Bustillo JR; Rowland LM; Jung R; Brooks WM; Qualls C; Hammond R; Hart B; Lauriello J
Neuropsychopharmacology; 2008 Sep; 33(10):2456-66. PubMed ID: 18094668
[TBL] [Abstract][Full Text] [Related]
13. Reduction of brain gamma-aminobutyric acid (GABA) concentrations in early-stage schizophrenia patients: 3T Proton MRS study.
Goto N; Yoshimura R; Moriya J; Kakeda S; Ueda N; Ikenouchi-Sugita A; Umene-Nakano W; Hayashi K; Oonari N; Korogi Y; Nakamura J
Schizophr Res; 2009 Jul; 112(1-3):192-3. PubMed ID: 19464152
[No Abstract] [Full Text] [Related]
14. Treatment response after 6 and 26 weeks is related to baseline glutamate and GABA levels in antipsychotic-naïve patients with psychosis.
Bojesen KB; Ebdrup BH; Jessen K; Sigvard A; Tangmose K; Edden RAE; Larsson HBW; Rostrup E; Broberg BV; Glenthøj BY
Psychol Med; 2020 Oct; 50(13):2182-2193. PubMed ID: 31524118
[TBL] [Abstract][Full Text] [Related]
15. Brain volume changes after withdrawal of atypical antipsychotics in patients with first-episode schizophrenia.
Boonstra G; van Haren NE; Schnack HG; Cahn W; Burger H; Boersma M; de Kroon B; Grobbee DE; Hulshoff Pol HE; Kahn RS
J Clin Psychopharmacol; 2011 Apr; 31(2):146-53. PubMed ID: 21346618
[TBL] [Abstract][Full Text] [Related]
16. Favorable effect on neuronal viability in the anterior cingulate gyrus due to long-term treatment with atypical antipsychotics: an MRSI study.
Braus DF; Ende G; Weber-Fahr W; Demirakca T; Henn FA
Pharmacopsychiatry; 2001 Nov; 34(6):251-3. PubMed ID: 11778146
[TBL] [Abstract][Full Text] [Related]
17. Proton magnetic resonance spectroscopy measures related to short-term symptomatic outcome in chronic schizophrenia.
Szulc A; Konarzewska B; Galinska-Skok B; Lazarczyk J; Waszkiewicz N; Tarasow E; Milewski R; Walecki J
Neurosci Lett; 2013 Jun; 547():37-41. PubMed ID: 23665527
[TBL] [Abstract][Full Text] [Related]
18. Proton magnetic resonance spectroscopy changes after antipsychotic treatment.
Szulc A; Galinska-Skok B; Waszkiewicz N; Bibulowicz D; Konarzewska B; Tarasow E
Curr Med Chem; 2013; 20(3):414-27. PubMed ID: 23157634
[TBL] [Abstract][Full Text] [Related]
19. Brain structural changes associated with chronicity and antipsychotic treatment in schizophrenia.
Tomelleri L; Jogia J; Perlini C; Bellani M; Ferro A; Rambaldelli G; Tansella M; Frangou S; Brambilla P;
Eur Neuropsychopharmacol; 2009 Dec; 19(12):835-40. PubMed ID: 19717283
[TBL] [Abstract][Full Text] [Related]
20. Abnormal Concentration of GABA and Glutamate in The Prefrontal Cortex in Schizophrenia.-An in Vivo 1H-MRS Study.
Chen T; Wang Y; Zhang J; Wang Z; Xu J; Li Y; Yang Z; Liu D
Shanghai Arch Psychiatry; 2017 Oct; 29(5):277-286. PubMed ID: 29276351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
